Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow-to-Debt Ratio
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow-to-debt ratio. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥26.54 Million could theoretically repay 0% of its total liabilities (CN¥715.31 Million) in one year. Check 002864 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
Cash flow-to-debt ratio of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Historical debt coverage capacity for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A across 13 annual periods. Check Shaanxi Panlong Pharmaceutical Group Lim cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow-to-Debt Ratio by Year (2013–2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A. For the full cash flow conversion analysis, see 002864 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥63.01 Million | CN¥633.75 Million | ▼ -59.2% |
| 2024 | 0.24x | CN¥156.59 Million | CN¥642.84 Million | ▲ +34.3% |
| 2023 | 0.18x | CN¥104.05 Million | CN¥573.76 Million | ▲ +42.2% |
| 2022 | 0.13x | CN¥125.36 Million | CN¥983.18 Million | ▼ -42.5% |
| 2021 | 0.22x | CN¥116.04 Million | CN¥522.97 Million | ▲ +2.7% |
| 2020 | 0.22x | CN¥92.24 Million | CN¥426.89 Million | ▼ -19.1% |
| 2019 | 0.27x | CN¥67.89 Million | CN¥254.17 Million | ▲ +17.6% |
| 2018 | 0.23x | CN¥46.85 Million | CN¥206.24 Million | ▲ +57.6% |
| 2017 | 0.14x | CN¥28.45 Million | CN¥197.34 Million | ▼ -58.9% |
| 2016 | 0.35x | CN¥61.99 Million | CN¥176.68 Million | ▲ +24.8% |
| 2015 | 0.28x | CN¥40.62 Million | CN¥144.44 Million | ▼ -10.2% |
| 2014 | 0.31x | CN¥48.56 Million | CN¥155.06 Million | ▲ +62.0% |
| 2013 | 0.19x | CN¥25.43 Million | CN¥131.55 Million | — |